Skip to content

Drug interactions

Danicopan + Tenofovir alafenamide

Severity: Moderate

Danicopan and Tenofovir alafenamide: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Danicopan inhibits P-glycoprotein and BCRP, which limit intestinal absorption of tenofovir alafenamide. Coadministration may raise tenofovir alafenamide exposure and thus tenofovir levels, although the increase is expected to be modest.

What this interaction means in plain words

Danicopan and Tenofovir alafenamide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Danicopan belongs to Miscellaneous; Tenofovir alafenamide belongs to Anti Virals.

Evidence level: Moderate

Why it happens

Danicopan inhibits intestinal P-gp and BCRP efflux, increasing absorption of tenofovir alafenamide.

What to do

Monitor for tenofovir-related adverse effects, particularly renal function and bone parameters, during coadministration. No empiric dose change is generally needed, but review if toxicity develops.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Danicopan and Tenofovir alafenamide, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Danicopan with Tenofovir alafenamide?

MediHelp rates the interaction as moderate. Danicopan and Tenofovir alafenamide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Danicopan inhibits P-glycoprotein and BCRP, which limit intestinal absorption of tenofovir alafenamide. Coadministration may raise tenofovir alafenamide exposure and thus tenofovir levels, although the increase is expected to be modest.

How serious is the interaction between Danicopan and Tenofovir alafenamide?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for tenofovir-related adverse effects, particularly renal function and bone parameters, during coadministration. No empiric dose change is generally needed, but review if toxicity develops.

What other medicines interact with Tenofovir alafenamide?

MediHelp also lists interactions of Tenofovir alafenamide with, for example, Apalutamide, Berotralstat, Ifosfamide. The full list is on the Tenofovir alafenamide page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in